A recent study provides evidence that in people without diabetes, six risk groups for cardiometabolic complications previously identified in middle-aged people can also be identified in older people. In cooperation with Helmholtz Munich, researchers at […]
A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of type 1 diabetes by targeting an inflammation-related protein known to drive the disease.This […]
An online physician-led plant-based nutrition intervention program for patients with type 2 diabetes is practical, cost-effective, and successful at improving patient health, finds a new study by the Physicians Committee for Responsible Medicine published in […]
In a new study led by scientists at the Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have determined that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier, an […]
A review by the American College of Physicians (ACP) of performance measures for diabetes found that of the 14 performance measures relevant to internal medicine, only four meet ACP’s rigorous standards for appropriate use, high-quality […]
Researchers at Pennington Biomedical Research Center have revealed critical insights into how impaired mitochondrial dynamics and quality control mechanisms in skeletal muscle influence insulin sensitivity in patients with type 2 diabetes, or T2D. The study, […]
A recent analysis of the SURPASS-3 trial unravels the impact of treatment with the drug tirzepatide on muscle volume and fat infiltration in individuals with type 2 diabetes.This article was originally published on MedicalXpress.com
Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes mellitus (T2DM). They are designed to lower high blood glucose levels typical in T2DM, and work by inhibiting the […]
Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a study published online April 22 in the […]
A new study published in Health Data Science by researchers at Peking University reveals a concerning rise in the prevalence of type 2 diabetes mellitus (T2DM) among depression inpatients in Beijing from 2005 to 2018. […]
© 2025 SimplyWell.ca